List view / Grid view
In this application note, PerkinElmer demonstrates the ease and utility of using AlphaLISA®, a homogeneous assay format, to screen for small molecular inhibitors of BET bromodomains.
2 January 2018 | By Charles River Laboratories
The webinar speakers highlight the collaboration between patient groups, charities, and academia led to the development of inhibitors targeting gliomas.
Massachusetts General Hospital (MGH) investigators use enzyme treatment to convert autoantibodies into anti-inflammatory antibodies in animal models of two autoimmune diseases.
A stem cell-derived in vitro model displays key small intestine characteristics including innate immune responses.
Direct application of immune cells speeds and improves healing of acute and chronic wounds in animal models...
A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans...
Scientists have uncovered two closely related cytokines molecules involved in cell communication that explain why some people develop progressive MS...
Immune cells could help to increase immune activity in vaccines or suppress immune reactions in autoimmune diseases...
Researchers have identified a novel variant "Delta 20" that suppresses the most damaging HIV strains...
Researchers have developed a test to diagnose a rare and severe immune defect...
Manipulation of the sugar metabolism and associated modulation of the immune system could open up new options for treating specific infectious and also autoimmune diseases...
Scientists at the University of Copenhagen have identified a unique cell surface protein present on human pancreatic precursor cells providing for the first time a molecular handle to purify the cells whose fate is to become cells of the pancreas - including insulin producing cells.
T cells may play an important role in Parkinson’s disease (PD), according to a new study...
Researchers have developed a new tools to increase immune response against cancer and infections...
A protein has been identified as a possible cause for the adverse reaction of the immune system in patients suffering from lupus.
